Sino Biological,Inc. (SHE:301047)

China · Delayed Price · Currency is CNY

73.10

-0.73 (-0.99%)

At close: May 12, 2026

20.87% (1Y)

Market Cap	8.98B +20.8%
Revenue (ttm)	727.69M +18.0%
Net Income	157.25M +56.0%
EPS	1.29 +61.7%
Shares Out	121.64M
PE Ratio	57.11
Forward PE	50.92
Dividend	5.20 (7.04%)
Ex-Dividend Date	Sep 22, 2025

Volume	1,455,150
Average Volume	1,123,756
Open	73.80
Previous Close	73.83
Day's Range	72.65 - 74.65
52-Week Range	60.07 - 85.00
Beta	0.81
RSI	52.74
Earnings Date	Apr 14, 2026

About Sino Biological,Inc.

Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers in China and internationally. The company offers recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification, qPCR primers, cell lysates, and purification reagents. It also provides comprehensive solutions, including autoimmune disease research, kinase drug discovery, cytokine and growth factor, SARS-CoV-2 variants research, comprehensive CAR-T therapy, 3D organoids research, ADC development, influenza vaccine dev... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2016

Employees 1,069

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301047

Full Company Profile

Financial Performance

In 2025, Sino Biological,Inc.'s revenue was 699.56 million, an increase of 14.00% compared to the previous year's 613.67 million. Earnings were 147.74 million, an increase of 21.17%.

Financial Statements